RR No. 18-2020: VAT Exemption on Prescription Drugs and Medicines for Diabetes, Hypertension, High Cholesterol, Cancer, Mental Illness, Tuberculosis, and Kidney Diseases

RR No. 18-2020 clarifies VAT exemption for approved prescription medicines, key disease categories, effective dates, and import VAT refund rules. Manufacturers, distributors, wholesalers, retailers, importers, hospitals, pharmacies, and corporate taxpayers dealing in covered prescription medicines must immediately review their VAT treatment because RR No. 18-2020 confirms that certain drugs and medicines are VAT-exempt, but only […]

RR No. 25-2018: VAT Exemption on Diabetes, High Cholesterol, and Hypertension Medicines Starting January 1, 2019

RR No. 25-2018 exempts FDA-listed diabetes, cholesterol, and hypertension medicines from VAT on local sale starting January 1, 2019. Starting January 1, 2019, businesses selling covered medicines for diabetes, high cholesterol, and hypertension must treat qualified sales as VAT-exempt, but only if the drug or medicine is included in the official VAT-exempt list identified and […]